Prostate Pathology Case Study Seminar

Overview

Journal Virchows Arch

Specialties Cell Biology
Molecular Biology
Pathology

Date 1997 Jan 1

PMID 9037320

Authors

R Montironi

E Alexander

D G Bostwick

Affiliations

Soon will be listed here.

Abstract

Great strides have been made in the past decade in our understanding of the pathology of the prostate. Diagnostic criteria have been proposed, debated, and refined for a number of entities, including prostatic intraepithelial neoplasia, atypical adenomatous hyperplasia, basal cell proliferations, postatrophic hyperplasia, verumontanum mucosal gland hyperplasia, and numerous new variants of prostatic adenocarcinoma such as ductal adenocarcinoma, mucinous carcinoma, signet ring cell carcinoma, and lymphoepithelioma-like carcinoma. This report presents a series of case studies in prostate pathology which illustrate some of the contemporary issues which confront the pathologist and urologist.

References

Kevwitch M, Walloch J, Waters W, Flanigan R . Prostatic cystic epithelial-stromal tumors: a report of 2 new cases. J Urol. 1993; 149(4):860-4. DOI: 10.1016/s0022-5347(17)36234-1. View

Kuhajda F, Mann R . Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen. Am J Clin Pathol. 1984; 81(2):257-60. DOI: 10.1093/ajcp/81.2.257. View

Lopez-Beltran A, Gaeta J, Huben R, Croghan G . Malignant phyllodes tumor of prostate. Urology. 1990; 35(2):164-7. DOI: 10.1016/0090-4295(90)80068-x. View

Smith D, MURPHY W . Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation. Cancer. 1994; 73(5):1472-7. DOI: 10.1002/1097-0142(19940301)73:5<1472::aid-cncr2820730525>3.0.co;2-m. View

Montironi R, Bartels P, Thompson D, Diamanti L, Prete E . Androgen-deprived prostate adenocarcinoma: evaluation of treatment-related changes versus no distinctive treatment effect with a Bayesian belief network. A methodological approach. Eur Urol. 1996; 30(3):307-15. DOI: 10.1159/000474188. View

TANNENBAUM M . Adenoid cystic or "salivary gland" carcinomas of prostate. Urology. 1975; 6(2):238-9. DOI: 10.1016/0090-4295(75)90724-4. View

Gaudin P, Wheeler T, Epstein J . Verumontanum mucosal gland hyperplasia in prostatic needle biopsy specimens. A mimic of low grade prostatic adenocarcinoma. Am J Clin Pathol. 1995; 104(6):620-6. DOI: 10.1093/ajcp/104.6.620. View

Armas O, Aprikian A, Melamed J, Cordon-Cardo C, COHEN D, Erlandson R . Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol. 1994; 18(10):979-91. DOI: 10.1097/00000478-199410000-00002. View

Remick Jr D, Kumar N . Benign polyps with prostatic-type epithelium of the urethra and the urinary bladder. A suggestion of histogenesis based on histologic and immunohistochemical studies. Am J Surg Pathol. 1984; 8(11):833-9. DOI: 10.1097/00000478-198411000-00003. View

10.

ALBERS D, STEPHENSON P . Metastatic carcinoma of the prostate from silent carcinoma of the stomach. A case report. J Okla State Med Assoc. 1962; 55:77-8. View

11.

Zein T, Huben R, Lane W, Pontes J, ENGLANDER L . Secondary tumors of the prostate. J Urol. 1985; 133(4):615-6. DOI: 10.1016/s0022-5347(17)49111-7. View

12.

Viskens D, Van Hove C, Fransen G, Bergmans G . [Phyllodes type of atypical prostatic hyperplasia]. Acta Chir Belg. 1991; 91(1):22-6. View

13.

Prahalada S, Keenan K, Hertzog P, Gordon L, Peter C, Soper K . Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor. Urology. 1994; 43(5):680-5. DOI: 10.1016/0090-4295(94)90184-8. View

14.

PERSAUD V, Douglas L . Bizarre (atypical) leiomyoma of the prostate gland. West Indian Med J. 1982; 31(4):217-20. View

15.

Leong S, Vogt P, Yu G . Atypical stromal smooth muscle hyperplasia of prostate. Urology. 1988; 31(2):163-7. DOI: 10.1016/0090-4295(88)90048-9. View

16.

Young R, Frierson Jr H, Mills S, Kaiser J, Talbot W, Bhan A . Adenoid cystic-like tumor of the prostate gland. A report of two cases and review of the literature on "adenoid cystic carcinoma" of the prostate. Am J Clin Pathol. 1988; 89(1):49-56. DOI: 10.1093/ajcp/89.1.49. View

17.

Gilmour A, Bell T . Adenoid cystic carcinoma of the prostate. Br J Urol. 1986; 58(1):105-6. DOI: 10.1111/j.1464-410x.1986.tb05443.x. View

18.

Dowd J . CARCINOMA OF THE PANCREAS PRESENTING AS OBSTRUCTING CANCER OF THE PROSTATE. Lahey Clin Found Bull. 1964; 13:204-5. View

19.

Bologna M, Muzi P, Biordi L, Festuccia C, Vicentini C . Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro. Urology. 1995; 45(2):282-90. DOI: 10.1016/0090-4295(95)80019-0. View

20.

Montironi R, Magi-Galluzzi C, Fabris G . Apoptotic bodies in prostatic intraepithelial neoplasia and prostatic adenocarcinoma following total androgen ablation. Pathol Res Pract. 1995; 191(9):873-80. DOI: 10.1016/s0344-0338(11)80971-4. View